Stock screener

HRTX

Conviction 20Scan · Mon, Aug 10, 2026
Three inside down
HRTX$0.3302-32.72%
ResistanceSupportVol 14
63 bars
Vol MA14 2.7M
May 11May 28Jun 16Jul 6Jul 23Aug 10
HERON THERAPEUTICS, INC. /DE/Pharmaceutical Preparationswww.herontx.com
Price0.3302
Change-32.72%
Gap-14.93%
Rel volume8.56×
Avg volume2.73M
Avg $ vol1.16M
SMA 200.4718
SMA 500.4603
SMA 2000.9630
Price vs 50-28.26%
Price vs 200-65.71%
MA stackbearish
50/200 cross
Supertrenddown · 0.5129
RSI (14)24
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D3 / 34
ADX (14)22
+DI / −DI14 / 36
RSI divergence
MACD divergenceBearish
ATR %+13.48%
ADR %8.23%
52w high1.49
52w low0.3302
From 52w high-77.84%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width33.30%
%B-0.40
Donchian pos2.51%
Donchian high0.5399
Donchian low0.3248
AVWAP (52w high)0.7655
vs AVWAP high-56.87%
AVWAP (52w low)0.3575
vs AVWAP low-7.64%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d8.56×
Avg vol (14d)2.7M
Avg vol (20d)2.73M
Avg $ vol (20d)1.16M
Market cap
RS 3m (vs SPY)-66.12%
RS 6m (vs SPY)-73.55%
RS line new highNo
Trend template0/8
Technical rank2.7
1 week-35.43%
1 month-20.32%
3 months-72.71%
6 months-73.79%
1 year-82.05%
YTD-73.79%
P/E-4.55
P/B10.05
P/S0.59
P/FCF-3.29
EPS-0.1200
Div yield
ROE-221.02%
ROA-8.20%
Debt/Eq
Current2.53
EV/EBITDA-293.23
Gross margin73.31%
Net margin-13.04%
Rev growth7.36%
EPS growth-48.71%
Price target
Target upside
Analyst rating
Institutional
Ent. value65.68M
Revenue34.71M
Net income-8.11M
Gross profit24.07M
Free cash flow-27.91M
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out189.28M
Employees128
ListedThu, Aug 27, 1987
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction20 / 100
Pattern quality
Tech rank2.7 / 100
Group rank
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmThree inside down
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HRTX

All disclosures →
No recent disclosed trades by Congress in HRTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HRTX · 6 buys · 4 sells

InsiderSideShares
Forbes William P
EVP, Chief Development Officer · Common Stock · 2026-06-06
Exercise12.5K
Forbes William P
EVP, Chief Development Officer · Restricted Stock Units · 2026-06-06
Exercise12.5K
Hensley Mark Earl
Chief Operating Officer · Common Stock · 2026-05-06
Exercise125K
Hensley Mark Earl
Chief Operating Officer · Restricted Stock Units · 2026-05-06
Exercise125K
Hensley Mark Earl
Chief Operating Officer · Restricted Stock Units · 2026-04-30
Exercise11.77K
Collard Craig A
Chief Executive Officer · Common Stock · 2026-04-30
Exercise34.79K
Duarte Ira
EVP, Chief Financial Officer · Restricted Stock Units · 2026-04-30
Exercise11.69K
Forbes William P
EVP, Chief Development Officer · Common Stock · 2026-04-30
Exercise11.77K
Hensley Mark Earl
Chief Operating Officer · Common Stock · 2026-04-30
Exercise11.77K
Duarte Ira
EVP, Chief Financial Officer · Common Stock · 2026-04-30
Exercise11.69K

SEC filings

EDGAR filings in HRTX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.